276 related articles for article (PubMed ID: 16301022)
21. Wireless pH monitoring in patients with non-cardiac chest pain.
Prakash C; Clouse RE
Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
[TBL] [Abstract][Full Text] [Related]
22. Ambulatory esophageal pH monitoring using a wireless system.
Pandolfino JE; Richter JE; Ours T; Guardino JM; Chapman J; Kahrilas PJ
Am J Gastroenterol; 2003 Apr; 98(4):740-9. PubMed ID: 12738450
[TBL] [Abstract][Full Text] [Related]
23. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
[TBL] [Abstract][Full Text] [Related]
24. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
Xiong LS; Chen MH; Lin JK; Hu PJ
J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
[TBL] [Abstract][Full Text] [Related]
25. The screening sensitivity of endoscopy, acid perfusion test and 24-hour pH-monitoring to evaluate esophagitis in patients with heartburn and histological esophagitis.
Navarro-Rodriguez T; de Moraes-Filho JP; Arakaki E; Chinzon D; Zaterka S; Iriya K; Laudanna AA
Arq Gastroenterol; 1997; 34(3):148-56. PubMed ID: 9611292
[TBL] [Abstract][Full Text] [Related]
26. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
[TBL] [Abstract][Full Text] [Related]
27. Wireless esophageal pH monitoring in children.
Gunnarsdóttir A; Stenström P; Arnbjörnsson E
J Laparoendosc Adv Surg Tech A; 2008 Jun; 18(3):443-7. PubMed ID: 18503382
[TBL] [Abstract][Full Text] [Related]
28. Functional chest pain responds to biofeedback treatment but functional heartburn does not: what is the difference?
Shapiro M; Shanani R; Taback H; Abramowich D; Scapa E; Broide E
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):708-14. PubMed ID: 22433792
[TBL] [Abstract][Full Text] [Related]
29. Relationship between endoscopic esophagitis and patterns of gastroesophageal reflux in ambulatory pHmetry.
Sánchez-Gey Venegas S; Yerro Páez VM; Pellicer Bautista FJ; Fuerte Seda M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 1999 Feb; 91(2):125-32. PubMed ID: 10231304
[TBL] [Abstract][Full Text] [Related]
30. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
31. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
[TBL] [Abstract][Full Text] [Related]
32. Area under pH 4: a more sensitive parameter for the quantitative analysis of esophageal acid exposure in adults.
Dinelli M; Passaretti S; Di Francia I; Fossati D; Tittobello A
Am J Gastroenterol; 1999 Nov; 94(11):3139-44. PubMed ID: 10566704
[TBL] [Abstract][Full Text] [Related]
33. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
[TBL] [Abstract][Full Text] [Related]
34. Acid sensitization of esophageal mucosal afferents: implication for symptom perception in patients across the gastroesophageal reflux disease spectrum.
Szczesniak MM; Fuentealba SE; Cook IJ
Clin J Pain; 2013 Jan; 29(1):70-7. PubMed ID: 22330131
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of different groups that comprise endoscopy-negative reflux disease].
Carmona-Sánchez R; Solana-Sentíes S; Esmer-Sánchez D; Tostado-Fernández JF
Rev Gastroenterol Mex; 2005; 70(1):6-13. PubMed ID: 16170956
[TBL] [Abstract][Full Text] [Related]
36. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
[TBL] [Abstract][Full Text] [Related]
37. Nonerosive reflux disease.
Waring JP
Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
[TBL] [Abstract][Full Text] [Related]
38. Relief of reflux symptoms after endoscopic gastroplication may be associated with reduced esophageal Acid sensitivity: a pilot study.
Wenzel G; Kuhlbusch R; Heise J; Frieling T
Endoscopy; 2005 Mar; 37(3):236-9. PubMed ID: 15731939
[TBL] [Abstract][Full Text] [Related]
39. 48-hour wireless oesophageal pH-monitoring in children: are two days better than one?
Gunnarsdóttir A; Stenström P; Arnbjörnsson E
Eur J Pediatr Surg; 2007 Dec; 17(6):378-81. PubMed ID: 18072019
[TBL] [Abstract][Full Text] [Related]
40. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
